molecules-logo

Journal Browser

Journal Browser

Peptide/Protein–Polymer Conjugates: Synthetic Design Strategies and Application

A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Macromolecular Chemistry".

Deadline for manuscript submissions: closed (30 November 2019)

Special Issue Editor


E-Mail Website
Guest Editor
Department of Chemistry, The University of Warwick, Coventry, UK
Interests: organic chemistry; polymer chemistry; bioconjugation; (bio)macromolecular self-assembly; antimicrobial/therapeutic peptides; redox active protein/peptides; electrochemical synthesis; electrochemical surface modification; nanofabrication

Special Issue Information

Dear Colleagues,

In nature post-translational modifications of peptides/proteins are essential in controlling the complexity and function of biomacromolecules. These modifications are efficient and site specific, with sophisticated cell machinery and biomolecular chaperones responsible for directing the structure, function, and activity of the biomolecules throughout. As synthetic chemists, we strive to mimic the complexity and sophistication of nature through chemical transformations and many methods have been developed through which peptides/proteins can be modified with functional small and/or macromolecules, which we refer to as bioconjugation. Likewise, in polymer chemistry, recent advances in synthetic methodology have led to the emergence of precision polymer synthesis. Radical, ionic and iterative step-growth methods have been developed that allow synthetic macromolecules to be designed and synthesized with unprecedented control over the polymer chain-ends and/or side-chain functionality. Incorporating functional groups that promote efficient and specific bioconjugation into these controlled polymers can promote macromolecular modification of peptides/proteins, with ever-improving site-specificity. The well-defined protein/peptide-polymer hybrid materials formed benefit from the amalgamation of the properties of proteins/peptides with those of synthetic macromolecules. This special issue of Molecules will focus on latest synthetic design strategies for peptide/polymer conjugation, particularly in the context on their potential applications which can range from home and personal care, to healthcare and drug-delivery.

Dr. Paul Wilson
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Bioconjugation
  • Biomacromolecules
  • Therapeutic peptides/proteins
  • Drug delivery
  • Controlled polymer synthesis
  • Precision polymer synthesis

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop